(R)-2-METHYL-6-NITRO-2-((4-(4-(4-(TRIFLUOROMETHOXY)PHENOXY)PIPERIDIN-1-YL)PHENOXY)METHYL)-2,3-DIHYDROIMIDAZO[2,1-B]OXAZOLE, 95%, 25mg

6-Nitroquinolin-5-ol, 95.0%, 250mg

5,6-Dihydro-4H-cyclopenta[b]thiophene-2-carboxylic acid, 97.0%, 1g

4-Nitrobenzyl (4R,5S,6S)-3-[(Diphenylphosphono)oxy]-6-[(R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate>98.0%(HPLC)(T)25g

Lithium metaborate, min. 98%, pa, ACS, anhydrous, 100 g, plastic packaging.

5-Bromo-2-methoxynicotinonitrile, 95.0%, 25g

N-(tert-butoxycarbonyl)-N-(cyclohexylmethyl)glycine, 98%, 500mg

1-(2-Chloro-4-methylsulfanyl-phenyl)-ethanone, 90.0%, 1g

Perfluorophenyl 4-(3,5-dimethyl-1H-pyrazol-1-yl)benzoate, 98%, 250mg

(S)-2-ACETAMIDO-4,4-DIMETHYLPENTANOIC ACID, 97%, 5g

1-(4-iso-Butylphenyl)ethanol, 97.0%, 10g

1-tert-Butyl 3-methyl 3-ethyl-4-oxopiperidine-1,3-dicarboxylate, 97%, 2g

3-(Trifluoromethyl)pyridine-2-carboxylic Acid>98.0%(GC)(T)500mg